Axonics (AXNX)
(Delayed Data from NSDQ)
$70.24 USD
-0.04 (-0.06%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $70.24 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$70.24 USD
-0.04 (-0.06%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $70.24 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Zacks News
Axonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axonics (AXNX) Looks Good: Stock Adds 7.4% in Session
by Zacks Equity Research
Axonics (AXNX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Reasons to Hold AptarGroup (ATR) Stock in Your Portfolio Now
by Zacks Equity Research
Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.
Axonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axonics Modulation's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Axonics Modulation Technologies.
Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Axonics (AXNX) delivered earnings and revenue surprises of 23.21% and 87.56%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Axonics Modulation Technologies (AXNX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axonics Modulation Technologies (AXNX) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Axonics (AXNX) delivered earnings and revenue surprises of -17.19% and -0.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Axonics Modulation Technologies (AXNX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axonics Modulation Technologies (AXNX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Axonics (AXNX) delivered earnings and revenue surprises of -21.92% and -9.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Axonics (AXNX) Upbeat on Results of Its ARTISAN-SNM Study
by Zacks Equity Research
Axonics (AXNX) expects to improve performance on the positive outcome of the study.
Ciena (CIEN) to Report Q1 Earnings: A Beat in the Offing?
by Zacks Equity Research
Ciena's (CIEN) fiscal first-quarter earnings are likely to gain from year-over-year higher revenues resulting from its long-term investments to meet customer needs.